Use of fosfluridine tidoxil (FT) for the treatment of intraepithelial proliferative diseases
Details for Australian Patent Application No. 2007271980 (hide)
International Classifications
Event Publications
15 January 2009 PCT application entered the National Phase
PCT publication WO2008/006511 Priority application(s): WO2008/006511
19 February 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Heidelberg Pharma AG, Application No. 2007271980, under INID(54) amend the title to read Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007271985-Active ingredient combinations with insecticidal and acaricidal properties
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser